See also this year's filing and all EDGAR filings for this company.
PDF Report 0001274792_2019_Merrimack_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss': 21, '100040 - Statement - Consolidated Statements of Operations and Comprehensive Loss2': 2}} |
Graph
Absolute values for 0001274792, Merrimack Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 76,102,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,269,000 |
| 3 | remainder_Assets | 10,172,000 |
| 4 | LiabilitiesCurrent | 14,795,000 |
| 5 | LiabilitiesNoncurrent | 56,000 |
| 6 | remainder_Liabilities | 14,873,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,983,963 |
| 9 | ResearchAndDevelopmentExpense | 46,836,311 |
| 10 | remainder_Expenses | -7,709,720 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 514,001,781 |
| 13 | remainder_ComprehensiveNetIncome | 304,217 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 88,543,000 |
| 1 | Liabilities | 29,724,000 |
| 2 | Expenses | 53,110,554 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 58,819,000 |
| 5 | NetIncome | 460,891,227 |
| 6 | ComprehensiveNetIncome | 461,043,336 |
| 7 | BaseVar | 342,841,776 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 9.97 |
| 9 | EconomicCapitalRatio | 9.97 |
Edgar->Model Mapping
Feature Distribution
Change over Time
